Antibodies against LDHA (Cell Signaling Technology, Danvers, MA, USA, 3582, 1:2500),
DOT1L (Cell Signaling Technology, 77087, 1:1000),
H3K79me2 (Cell Signaling Technology, 5427, with 1:1000),
BCAT1 (Cell Signaling Technology, Cat.88785, 1:1000),
Tubulin (Santa Cruz, Santa Cruz, CA, USA, Cat. sc-5286, 1:2000),
Lamin B1 (Cell Signaling Technology, Cat.13435, 1:2000),
β-actin (Santa Cruz, Cat. sc-047778, 1:2000), and
GAPDH (Santa Cruz, Cat.sc-47724, 1:2000) were used for Western blotting.
Antibodies against LDHA (Cell Signaling Technology, 3582, 1:500),
BCAT1 (Cell Signaling Technology, Cat.88785, 1:500), GCLM (Proteintech, Rosemont, IL, USA, Cat.14241, 1:500), and
TXNRD1 (Proteintech, Cat.11117, 1:500) were used for immunohistochemistry staining (IHC).
Hydrogen peroxide solution (H
2O
2) (Sigma, St. Louis, MO, USA, Cat.323381),
N-acetyl cysteine (NAC) (Sigma, Cat.A7250),
DAPI (Sigma, Cat.D9542), sodium 2-hydroxybutyrate (Santa Cruz, Cat. sc-258161),
sulfasalazine (SSA) (Sigma, Cat.S0087), and
EPZ004777 (Selleck, Washington, DC, USA, Cat.S7353) were commercially obtained.
Li Z., Gu Z., Wang L., Guan Y., Lyu Y., Zhang J., Wang Y., Wang X., Xiong J, & Liu Y. (2023). Nuclear Translocation of LDHA Promotes the Catabolism of BCAAs to Sustain GBM Cell Proliferation through the TxN Antioxidant Pathway. International Journal of Molecular Sciences, 24(11), 9365.